Successful treatment of infected residual pleural space after pulmonary resection with autologous platelet-leukocyte gel.
Complications of the residual pleural space after pulmonary resection have been reported to be between 5% and 40% depending on the type of resection, and they increase morbidity, mortality, hospital stays, and costs. The therapeutic use of autologous prepared platelet leukocyte-enriched gel is a relatively new technology for the stimulation and acceleration of soft tissue and bone healing. This gel can be applied to a diversity of tissue. We describe the case of a successful application through a chest tube of platelet leukocyte gel to treat an infected residual pleural space that developed after pulmonary lobectomy for lung cancer.
Department of Thoracic Surgery, University of Roma Sapienza, Rome, Italy. tiziano.degiacomo@tin.it
Tiziano
T
De Giacomo
Daniele
D
Diso
Giancarlo
G
Ferrazza
Federico
F
Venuta
Federico
F
Francioni
Giorgio F
GF
Coloni
D000368:Aged; D002177:Candidiasis / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000601:surgery; D005782:Gels; D006801:Humans; D017708:Leukocyte Transfusion; D008175:Lung Neoplasms / Q000601:surgery; D008297:Male; D017713:Platelet Transfusion; D010995:Pleural Diseases / Q000628:therapy*; D011013:Pneumonectomy; D011183:Postoperative Complications / Q000628:therapy*; D012074:Remission Induction; D013203:Staphylococcal Infections / Q000628:therapy*
D005782:Gels